Glenmede Disciplined U.S. Small Cap Equity Portfolio (GQSCX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
16.50
+0.02 (0.12%)
Feb 17, 2026, 9:30 AM EST
Fund Assets2.59M
Expense Ratio0.85%
Min. Investment$1,000
Turnover92.00%
Dividend (ttm)0.46
Dividend Yield2.81%
Dividend Growth-69.61%
Payout FrequencyQuarterly
Ex-Dividend DateDec 15, 2025
Previous Close16.48
YTD Return6.94%
1-Year Return19.18%
5-Year Return67.71%
52-Week Low10.70
52-Week High16.71
Beta (5Y)1.05
Holdings132
Inception DateNov 13, 2017

About GQSCX

The Glenmede Fund, Inc. Quantitative U.S. Small Cap Equity Portfolio is a mutual fund that seeks maximum long-term total return consistent with reasonable risk to principal by investing primarily in U.S. small-cap common stocks. It employs a disciplined, proprietary multi-factor quantitative model for stock selection across various sectors, integrating top-down and bottom-up analysis, downside risk screens, and industry indicators. The portfolio typically holds around 130 stocks from economically U.S.-tied small companies, with a focus on growth and income. Its expense ratio stands at 0.85%, positioning it in the lower cost tier among its peers. The fund's investment strategy balances favorable valuation and risk metrics, aiming to outperform the Russell 2000 Index, a key benchmark for small-cap equities. Its diversified holdings span sectors such as consumer cyclical, technology, healthcare, and industrials, reflecting a comprehensive approach to small-cap equity exposure. Established in 2017, this fund serves investors seeking disciplined, quantitative exposure to the U.S. small-cap equity market segment while maintaining attention to risk management and cost efficiency.

Fund Family Glenmede
Category Small Value
Performance Rating Above Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol GQSCX
Index Russell 2000 TR

Performance

GQSCX had a total return of 19.18% in the past year, including dividends. Since the fund's inception, the average annual return has been 15.57%.

Top 10 Holdings

14.29% of assets
NameSymbolWeight
Relay Therapeutics, Inc.RLAY2.20%
DNOW Inc.DNOW1.54%
EZCORP, Inc.EZPW1.41%
Pacira BioSciences, Inc.PCRX1.39%
Constellium SECSTM1.36%
Hamilton Insurance Group, Ltd.HG1.33%
Resideo Technologies, Inc.REZI1.32%
Digi International Inc.DGII1.26%
Castle Biosciences, Inc.CSTL1.26%
Allient Inc.ALNT1.22%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 15, 2025$0.4256Dec 16, 2025
Oct 1, 2025$0.0289Oct 6, 2025
Apr 2, 2025$0.0094Apr 7, 2025
Dec 16, 2024$1.4706Dec 17, 2024
Oct 2, 2024$0.0122Oct 7, 2024
Jul 3, 2024$0.038Jul 8, 2024
Full Dividend History